Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shona Fielding

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
The Lancet. Gastroenterology & Hepatology|August 15, 2025
Endoscopist deskilling risk after exposure to artificial intelligence in colonoscopy: a multicentre, observational studyKrzysztof Budzyń, Marcin Romańczyk, Diana Kitala, et al.
Health Technology Assessment (Winchester, England)|May 19, 2025
Bisoprolol for patients with chronic obstructive pulmonary disease at high risk of exacerbation: the BICS RCTGraham Devereux, Seonaidh Cotton, Mintu Nath, et al.
European Journal of Cancer (Oxford, England : 1990)|May 14, 2025
Body mass index and weight changes in patients with HER2-positive early breast cancer: A sub-analysis of the APHINITY trialChiara Dauccia, Maria Alice Franzoi, Samuel Martel, et al.
Lancet (London, England)|May 8, 2026
Long-term effects of colonoscopy screening on colorectal cancer incidence and mortality: a multicountry, population-based randomised controlled trialMichal F Kaminski, Mette Kalager, Magnus Løberg, et al.
JAMA|May 19, 2024
Bisoprolol in Patients With Chronic Obstructive Pulmonary Disease at High Risk of Exacerbation: The BICS Randomized Clinical TrialGraham Devereux, Seonaidh Cotton, Mintu Nath, et al.
Journal of the National Cancer Institute|May 5, 2022
Impact of Age on Clinical Outcomes and Efficacy of Adjuvant Dual Anti-HER2 Targeted TherapyMatteo Lambertini, Shona Fielding, Sibylle Loibl, et al.
European Journal of Cancer (Oxford, England : 1990)|January 15, 2023
Ten-year survival of neoadjuvant dual HER2 blockade in patients with HER2-positive breast cancerPaolo Nuciforo, John Townend, Martine J Piccart, et al.
Trials|April 15, 2022
Use of the oral beta blocker bisoprolol to reduce the rate of exacerbation in people with chronic obstructive pulmonary disease (COPD): a randomised controlled trial (BICS)Seonaidh Cotton, Graham Devereux, Hassan Abbas, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
The Lancet. Gastroenterology & Hepatology|August 15, 2025
Endoscopist deskilling risk after exposure to artificial intelligence in colonoscopy: a multicentre, observational studyKrzysztof Budzyń, Marcin Romańczyk, Diana Kitala, et al.
Health Technology Assessment (Winchester, England)|May 19, 2025
Bisoprolol for patients with chronic obstructive pulmonary disease at high risk of exacerbation: the BICS RCTGraham Devereux, Seonaidh Cotton, Mintu Nath, et al.
European Journal of Cancer (Oxford, England : 1990)|May 14, 2025
Body mass index and weight changes in patients with HER2-positive early breast cancer: A sub-analysis of the APHINITY trialChiara Dauccia, Maria Alice Franzoi, Samuel Martel, et al.
Lancet (London, England)|May 8, 2026
Long-term effects of colonoscopy screening on colorectal cancer incidence and mortality: a multicountry, population-based randomised controlled trialMichal F Kaminski, Mette Kalager, Magnus Løberg, et al.
JAMA|May 19, 2024
Bisoprolol in Patients With Chronic Obstructive Pulmonary Disease at High Risk of Exacerbation: The BICS Randomized Clinical TrialGraham Devereux, Seonaidh Cotton, Mintu Nath, et al.
Journal of the National Cancer Institute|May 5, 2022
Impact of Age on Clinical Outcomes and Efficacy of Adjuvant Dual Anti-HER2 Targeted TherapyMatteo Lambertini, Shona Fielding, Sibylle Loibl, et al.
European Journal of Cancer (Oxford, England : 1990)|January 15, 2023
Ten-year survival of neoadjuvant dual HER2 blockade in patients with HER2-positive breast cancerPaolo Nuciforo, John Townend, Martine J Piccart, et al.
Trials|April 15, 2022
Use of the oral beta blocker bisoprolol to reduce the rate of exacerbation in people with chronic obstructive pulmonary disease (COPD): a randomised controlled trial (BICS)Seonaidh Cotton, Graham Devereux, Hassan Abbas, et al.
Pageof 7